Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for t...

著者: Bianchini, Giampaolo, Kiermaier, Astrid, Bianchi, Giulia Valeria, Im, Young-Hyuck, Pienkowski, Tadeusz, Liu, Mei-Ching, Tseng, Ling-Ming, Dowsett, Mitch, Zabaglo, Lila, Kirk, Sarah, Szado, Tania, Eng-Wong, Jennifer, Amler, Lukas C., Valagussa, Pinuccia, Gianni, Luca
出版年 Breast Cancer Res (2017)

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

著者: Barrios, Carlos H., Liu, Mei-Ching, Lee, Soo Chin, Vanlemmens, Laurence, Ferrero, Jean-Marc, Tabei, Toshio, Pivot, Xavier, Iwata, Hiroji, Aogi, Kenjiro, Lugo-Quintana, Roberto, Harbeck, Nadia, Brickman, Marla J., Zhang, Ke, Kern, Kenneth A., Martin, Miguel
出版事項 2010

Health-Related Quality of Life With Adjuvant Docetaxel- and Trastuzumab-Based Regimens in Patients with Node-Positive and High-Risk Node-Negative, HER2-Positive Early Breast Cancer...

著者: Au, Heather-Jane, Eiermann, Wolfgang, Robert, Nicholas J., Pieńkowski, Tadeusz, Crown, John, Martin, Miguel, Pawlicki, Marek, Chan, Arlene, Mackey, John, Glaspy, John, Pintér, Tamás, Liu, Mei-Ching, Fornander, Tommy, Sehdev, Sandeep, Ferrero, Jean-Marc, Bée, Valerie, Santana, Maria J., Miller, Dave P., Lalla, Deepa, Slamon, Dennis J.
出版事項 2013

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

著者: Slamon, Dennis, Eiermann, Wolfgang, Robert, Nicholas, Pienkowski, Tadeusz, Martin, Miguel, Press, Michael, Mackey, John, Glaspy, John, Chan, Arlene, Pawlicki, Marek, Pinter, Tamas, Valero, Vicente, Liu, Mei-Ching, Sauter, Guido, von Minckwitz, Gunter, Visco, Frances, Bee, Valerie, Buyse, Marc, Bendahmane, Belguendouz, Tabah-Fisch, Isabelle, Lindsay, Mary-Ann, Riva, Alessandro, Crown, John
出版事項 2011